News

FDA clears Papzimeos to treat adult respiratory papillomatosis

The Food and Drug Administration approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults with recurrent ...
Just The News5h

FDA starts 'real-time reporting of adverse event data' for first time

The U.S. Food and Drug Administration has started "real-time reporting of adverse event data," according to an annoucement ...

US FDA approves Ionis' drug for rare genetic disorder

By Sneha S K and Bageshri Banerjee (Reuters) -The U.S. Food and Drug Administration on Thursday approved Ionis ...

FDA Clears OTC Glucose Monitoring System for Weight Management

System integrates glucose biosensor with an AI-driven platform to show how food, activity, stress, sleep affect the body in ...

Noodle Recall Update as FDA Issues Risk Warning

The FDA classifies this recall as Class II, which the agency describes as a situation "in which use of or exposure to a ...

People’s Pharmacy: Is there a way to petition the FDA to change a drug’s classification?

A. The Food and Drug Administration has approved montelukast to treat asthma, exercise-induced bronchoconstriction (trouble ...

FDA Announces Recall on Over 20,000 Cans of 7Up—Here’s What to Know

FDA recalls 7Up Zero Sugar Tropical Soda for being mislabeled full-sugar soda. The affected cans were sold in 12-packs in ...

Leading Researchers Reject FDA’s Position, Find No Evidence of Harm From 7-OH in Response From Shaman Botanicals to FDA

Shaman Botanicals has issued a formal response to the FDA’s recent warning letter on its 7-hydroxymitragynine (7-OH) products ...

Time is running out for kids with a rare disease, parents say, unless the FDA acts

After a more than decadelong process to bring the experimental drug elamipretide to market, the treatment’s approval has ...

Outlook Therapeutics: Why The Odds Point To A Favorable FDA Decision

Outlook Therapeutics nears FDA decision on Lytenava, with EU sales, exclusivity, and high upside potential despite current ...